Published in Wien Klin Wochenschr on January 29, 2013
Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program. Hum Vaccin Immunother (2014) 0.80
Effectiveness of hepatitis A vaccination as post-exposure prophylaxis. Hum Vaccin Immunother (2016) 0.75
The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies. J Infect Dis (1998) 2.68
Hepatitis A. Lancet (1998) 2.35
Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect (2004) 2.20
Hepatitis A: a vaccine at last. Lancet (1992) 2.02
Hepatitis A and E: update on prevention and epidemiology. Vaccine (2009) 2.00
T and B lymphocytes in acute and chronic hepatitis. Clin Immunol Immunopathol (1974) 1.98
Fulminant hepatitis A virus infection in the United States: Incidence, prognosis, and outcomes. Hepatology (2006) 1.83
Hepatitis A: old and new. Clin Microbiol Rev (2001) 1.82
Hepatitis A in the era of vaccination. Epidemiol Rev (2006) 1.75
Atypical clinical manifestations of hepatitis A. Vaccine (1992) 1.33
Hepatitis A: clinical manifestations and management. Intervirology (2010) 1.28
Clinical course and consequences of hepatitis A infection. Vaccine (2000) 1.25
Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics (2000) 1.07
Acute hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat (2008) 1.01
Hepatitis A among schoolchildren in a US-Mexico border community. Am J Public Health (1997) 0.92
-glutamyl-transpeptidase in diseases of the liver, cardiovascular system and diabetes mellitus. Clin Chim Acta (1972) 0.87
The role of vaccine in controlling hepatitis A epidemics. Vaccine (2003) 0.87
Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand. J Clin Virol (2005) 0.86
Increase in hepatitis A cases in the Czech Republic in 2008 - an update. Euro Surveill (2009) 0.83
Hepatitis A vaccines. Expert Rev Vaccines (2008) 0.83
Long-term protective effect of post-exposure Havrix administration during viral hepatitis Type A outbreaks. Eur J Epidemiol (2006) 0.80
Hepatitis A in the European Union: responding to challenges related to new epidemiological patterns. Euro Surveill (2009) 0.80
An outbreak of hepatitis A in school children at Nakhon Si Thammarat, southern Thailand. Southeast Asian J Trop Med Public Health (1995) 0.78
[Etiology of acute viral hepatitis in a pediatric population]. Medicina (B Aires) (1985) 0.75
Pathogenesis of viral hepatitis. Baillieres Clin Gastroenterol (1990) 0.75
[Antibodies against hepatitis A virus in the healthy (author's transl)]. Cas Lek Cesk (1981) 0.75
Infectious hepatitis; clinical and laboratory features of 295 cases. Am J Med Sci (1947) 0.75
Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect Dis (2002) 1.67
Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization. Eur Heart J (2007) 1.40
Prevalence and risk factors of poor posture in school children in the Czech Republic. J Sch Health (2007) 0.95
Pneumococcal urinary antigen positivity in healthy colonized children: is it age dependent? Wien Klin Wochenschr (2013) 0.84
Impacts of hot and cold spells differ for acute and chronic ischaemic heart diseases. BMC Public Health (2014) 0.82
Incidence and clinical and immunological characteristics of primary Toxoplasma gondii infection in HIV-infected patients. Int J Infect Dis (2013) 0.82
Prevalence and incidence of Toxoplasma infection in HIV-positive patients in the Czech Republic. J Eukaryot Microbiol (2006) 0.81
Serum concentrations of indicator PCB congeners in the Czech adult population. Chemosphere (2008) 0.81
Levels of PCDDs, PCDFs, and PCBs in the blood of the non-occupationally exposed residents living in the vicinity of a chemical plant in the Czech Republic. Chemosphere (2007) 0.80
Association of size-resolved number concentrations of particulate matter with cardiovascular and respiratory hospital admissions and mortality in Prague, Czech Republic. Inhal Toxicol (2010) 0.80
Presence of herpesvirus DNA in cerebrospinal fluid of patients with tick-borne encephalitis and enteroviral meningoencephalitis. J Med Virol (2015) 0.80
Association between ambient ozone and health outcomes in Prague. Int Arch Occup Environ Health (2012) 0.79
Cytokines and chemokines as biomarkers of community-acquired bacterial infection. Mediators Inflamm (2013) 0.78
Prevalence of human leukocyte antigen HLA-B*57:01 in HIV-infected subjects in the Czech Republic. Cent Eur J Public Health (2011) 0.78
A study of HIV-1 genetic diversity in the Czech Republic: 1986-2007. Cent Eur J Public Health (2008) 0.75
[Severe eosinophilia in a patient with clostridium colitis and gastric cancer]. Klin Mikrobiol Infekc Lek (2013) 0.75
Enteric fever imported to the Czech Republic: epidemiology, clinical characteristics and antimicrobial susceptibility. Folia Microbiol (Praha) (2014) 0.75
[Dengue fever cases in Czech workers returning from the Maldives]. Epidemiol Mikrobiol Imunol (2013) 0.75
[Fever of unknown origin: case reports from routine clinical practice and a review]. Klin Mikrobiol Infekc Lek (2021) 0.75
[Listeriosis in pregnant women and newborns in Czech Republic]. Klin Mikrobiol Infekc Lek (2010) 0.75
[Phylogenetic analysis and genotyping of A/H3N2 Influenza viruses isolated from patients hospitalised with influenza-like illness symptoms in the na bulovce hospital in the season 2011/2012]. Epidemiol Mikrobiol Imunol (2013) 0.75
[Incidence of tick-borne encephalitis in the czech republic in 2001-2011 in different administrative regions and municipalities with extended power]. Epidemiol Mikrobiol Imunol (2013) 0.75
Eye irritation hazard of chemicals and formulations assessed by methods in vitro. Neuro Endocrinol Lett (2014) 0.75
Bohumír Procházka, longtime CEJPH Editorial Board member, dies at 64. Cent Eur J Public Health (2017) 0.75